deltatrials
Active Not Recruiting PHASE3 INTERVENTIONAL 2-arm NCT01878669

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention (EASE-PCI)

Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention

Sponsor: Suleyman Demirel University

Conditions Coronary Artery Disease
Interventions N-acetyl cysteine Saline
Updated 18 times since 2017 Last updated: May 17, 2025 Started: Jan 31, 2013 Primary completion: Sep 30, 2017 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Coronary Artery Disease and is currently ongoing. Suleyman Demirel University leads this study, which shows 18 recorded versions since 2013 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Aug 2019 · 9 months · monthly snapshot~Aug 2019 – ~Apr 2020 · 8 months · monthly snapshot~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Sep 2022 · 7 months · monthly snapshot~Sep 2022 – ~Sep 2023 · 12 months · monthly snapshot~Sep 2023 – ~May 2024 · 8 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE3

  2. Jun 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE3

  3. Sep 2024 — Jun 2025 [monthly]

    Active Not Recruiting PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  5. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

▶ Show 13 earlier versions

  1. Sep 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Sep 2022 — Sep 2023 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE3

  4. Oct 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE3

  5. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE3

  6. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  7. Apr 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE3

  8. Aug 2019 — Apr 2020 [monthly]

    Active Not Recruiting PHASE3

  9. Nov 2018 — Aug 2019 [monthly]

    Active Not Recruiting PHASE3

  10. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE3

  11. Nov 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  12. Feb 2017 — Nov 2017 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  13. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Suleyman Demirel University
Data source: Suleyman Demirel University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations